Can a simple protein tame Sepsis's fiery inflammation?

NCT ID NCT03950778

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial asks whether giving extra albumin—a key protein in the blood—can lower inflammation and oxidative stress in people with sepsis, a severe infection that can cause organ failure. Adults in intensive care with sepsis and low albumin levels are randomly assigned to receive either albumin infusions for three days or standard care. Researchers will track changes in inflammatory markers like C-reactive protein and procalcitonin, as well as antioxidant capacity, to see if albumin supplementation offers a protective effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Human albumin solution (20%) given intravenously for three days
What this could lead to
If albumin helps, it could point toward a simple supportive therapy to ease inflammation and oxidative stress in sepsis patients in intensive care.
What could go wrong
This is a very early, small trial, so results may not be conclusive. Albumin is generally safe, but any IV therapy carries risks like allergic reactions or fluid overload.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALBUMIN SUPPLEMENTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universitty of Pecs Department of Anaesthesiology and Intensive Therapy

    Pécs, Ifjúság Str.13., 7624, Hungary

  • University of Pécs Department of Anaesthesiology and Intensive Therapy

    Pécs, Ifjúság Str 13., 7524, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.